Macroautophagy as a pathomechanism in sporadic inclusion body myositis

被引:2
|
作者
Lunemann, Jan D.
Schmidt, Jens
Dalakas, Marinas C.
Munz, Christian
机构
[1] Rockefeller Univ, Lab Viral Immunobiol, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA
[2] Univ Gottingen, Muscle Immunobiol Grp, Dept Neuroimmunol, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany
[4] NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
sporadic inclusion body myositis; beta-amyloid; macroautophagy; LC3/Atg8; vacuolar myopathy;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Skeletal muscle fibers show a high level of constitutive and starvation-induced macroautophagy. Sporadic Inclusion Body Myositis (sIBM) is the most common acquired skeletal muscle disease in patients above the age of 50 years and is characterized by inflammation and intracellular accumulation of aggregate-prone proteins such as amyloid precursor protein (APP)/beta-amyloid, hyperphosphorylated tau, and presenilin. In a recent study, we found that muscle fibers of sIBM patients show increased frequencies of Atg8/ LC3(+) autophagosomes and that intracellular APP/(i-amyloid colocalized with Atg8/LC3 in degenerating fibers. Colocalization of APP/beta-amyloid with LC3(+) autophagosomes was further associated with upregulation of major histocompatibility complex (MHC) class I and class II molecules and T cell infiltration. These findings indicate that APP/beta-amyloid is a substrate for autophagy in skeletal muscle fibers and suggest that degradation of aggregate-prone proteins via macroautophagy can be linked with both immune-mediated and degenerative tissue damage. A better understanding of this pathway in skeletal muscle and in the inflammatory environment of sIBM might provide a rationale for novel therapeutic strategies targeting pathogenic protein aggregation.
引用
收藏
页码:384 / 386
页数:3
相关论文
共 50 条
  • [31] CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
    Satoshi Yamashita
    Yoshimasa Matsuo
    Nozomu Tawara
    Kentaro Hara
    Masanori Yamamoto
    Tomo Nishikami
    Kensuke Kawakami
    Xiao Zhang
    Ziwei Zhang
    Tsukasa Doki
    Yukio Ando
    Scientific Reports, 9
  • [32] Cardiac Involvement in Sporadic Inclusion-Body Myositis
    Utz, Wolfgang
    Schmidt, Saskia
    Schulz-Menger, Jeanette
    Luft, Friedrich
    Spuler, Simone
    CIRCULATION, 2010, 121 (05) : 706 - 708
  • [33] Mitochondrial and inflammatory changes in sporadic inclusion body myositis
    Rygiel, K. A.
    Miller, J.
    Grady, J. P.
    Rocha, M. C.
    Taylor, R. W.
    Turnbull, D. M.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (03) : 288 - 303
  • [34] Mitochondrial DNA depletion in sporadic inclusion body myositis
    Bhatt, Padmanabh S.
    Tzoulis, Charalampos
    Balafkan, Novin
    Miletic, Hrvoje
    Gia Tuong Thi Tran
    Sanaker, Petter Schandl
    Bindoff, Laurence A.
    NEUROMUSCULAR DISORDERS, 2019, 29 (03) : 242 - 246
  • [35] Clinical and epidemiological analysis of sporadic inclusion body myositis
    Furuta, M.
    Natsumi, F.
    Kouki, M.
    Kazuaki, N.
    Fujita, Y.
    Ikeda, Y.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 289 - 289
  • [36] β-amyloid is a substrate of autophagy in sporadic inclusion body myositis
    Lunemann, Jan D.
    Schmidt, Jens
    Schmid, Dorothee
    Barthel, Konstanze
    Wrede, Arne
    Dalakas, Marinos C.
    Munz, Christian
    ANNALS OF NEUROLOGY, 2007, 61 (05) : 476 - 483
  • [37] Functional Impairment in Patients with Sporadic Inclusion Body Myositis
    Dunlap, Heather V.
    MacNeil, Lauren G.
    Tarnopolsky, Mark A.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2014, 41 (02) : 253 - 259
  • [38] CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
    Yamashita, Satoshi
    Matsuo, Yoshimasa
    Tawara, Nozomu
    Hara, Kentaro
    Yamamoto, Masanori
    Nishikami, Tomo
    Kawakami, Kensuke
    Zhang, Xiao
    Zhang, Ziwei
    Doki, Tsukasa
    Ando, Yukio
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Experience with abatacept treatment in sporadic inclusion body myositis
    Lindberg, C.
    Ewaldsson, A.
    Edofsson, U.
    Hammaren, E.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S237 - S237